Hikma Pharmaceuticals’ $375 Million Acquisition of Custopharm

Troutman Pepper advised Hikma Pharmaceuticals PLC on the deal.Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, has acquired Custopharm Inc. from Water Street Healthcare Partners, following approval…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now